Pre & Post FermeCare
A member of Shantel’s research team with damaged skin from trauma used FermeCare for a 90-day period, observing significant improvement in skin texture and firmness, as well as a high level of reduction of stress-induced hyperpigmentation.
FermeCare’s product performance was initially documented via a clinical study involving the treatment of Actinic Keratosis (AK) lesions using a gel made with the patented FermeCare process. Patients participating in this independent double-blinded study observed a 60 to 100% reduction in AK lesions within 90 days, without corresponding inflammation. Post-trial pathology also revealed skin showed increase thickness and improved texture after trial period application6
A trial test subject diagnosed with severe hyperpigmentation used FermeCare for a 30-day period, observing strong reduction in hyperpigmented lesions in the periorbital eye area as well as increased skin brightness and improv
A trial test subject diagnosed with hyperpigmentation the hands used FermeCare for a 15-day period, observing strong reduction in hyperpigmented lesions and a brighter skin tone.